FPH Fisher & Paykel Healthcare Corp. Ltd.
—Mkt Cap: —P/E: —Today
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationall…
Industry Peers
Medical Devices & SuppliesKey Statistics
Company
Market Cap—
Enterprise Value15.86B USD
Revenue (TTM)1.29B USD
Gross Profit823.35M USD
Net Income (TTM)262.39M USD
Revenue/Share3.93 NZD
Last Price—
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees7.4K
CountryNZ
SectorHealthcare
IndustryMedical Devices & Supplies
ISINNZFAPE0001S2
Valuation
P/E (Trailing)—
P/E (Forward)44.54
PEG43.64
EV/EBITDA37.29
EV/Revenue12.27
P/S12.41
P/B13.51
EPS (TTM)0.79
EPS (Forward)1.09
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin63.68%
Oper. Margin28.72%
EBITDA Margin32.90%
Profit Margin20.30%
ROE22.15%
ROA16.42%
Growth
Revenue Growth14.00%
Earnings Growth14.30%
Cash Flow & Leverage
Operating CF371.43M USD
CapEx (TTM)109.32M USD
FCF Margin17.30%
FCF Yield—
Net Debt-176.42M USD
Net Debt/EBITDA-0.41
Balance Sheet
Debt/Equity0.07
Current Ratio2.31
Quick Ratio1.61
Book Value/Sh3.60 NZD
Cash/Share0.79 NZD
Dividends
Fwd Div Rate—
Trail. Div Rate0.52 NZD
Div. Yield1.07%
5Y Avg Yield1.39%
Payout Ratio54.22%
Ex-Div DateJun 22, 2026
Pay Date—
Splits
Last Split5:1
Split DateOct 4, 2004
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)45.19 NZD
Target Range30.50 NZD – 52.00 NZD
# Analysts11
Ownership
Shares Out.588.27M
Float584.99M
Insiders3.68%
Institutions38.58%
Technical
SMA 5044.68 NZD
SMA 20039.83 NZD
Beta0.88
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)494.09K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—